Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Whitehawk Therapeutics (WHWK) Accumulated Depreciation & Amortization (2018 - 2025)

Whitehawk Therapeutics (WHWK) has disclosed Accumulated Depreciation & Amortization for 7 consecutive years, with $374000.0 as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 93.78% to $374000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $374000.0 through Dec 2025, up 93.78% year-over-year, with the annual reading at $374000.0 for FY2025, 93.78% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $374000.0 at Whitehawk Therapeutics, roughly flat from $373000.0 in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $416000.0 in Q3 2024, with the low at $38000.0 in Q1 2023.
  • Average Accumulated Depreciation & Amortization over 5 years is $203529.4, with a median of $159000.0 recorded in 2022.
  • The sharpest move saw Accumulated Depreciation & Amortization tumbled 48.65% in 2023, then soared 604.0% in 2025.
  • Over 5 years, Accumulated Depreciation & Amortization stood at $105000.0 in 2021, then skyrocketed by 51.43% to $159000.0 in 2022, then grew by 6.29% to $169000.0 in 2023, then grew by 14.2% to $193000.0 in 2024, then soared by 93.78% to $374000.0 in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $374000.0, $373000.0, and $368000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.